Comprehensive Global Review Finds Ginkgo Biloba Offers No Benefit for Mild Memory Loss but Modest Gains in Dementia Cases

Georgetown study finds Ginkgo biloba offers modest help for dementia symptoms but no benefit for mild cognitive impairment or memory loss in MS patients.

By: AXL Media

Published: Mar 10, 2026, 12:26 PM EDT

Reevaluating the Clinical Efficacy of Ginkgo Biloba

An international research team has completed one of the most exhaustive evaluations of Ginkgo biloba to date, providing much-needed clarity on the popular supplement's role in brain health. Led by the Georgetown University School of Medicine, the study analyzed 82 trials involving more than 10,000 participants to determine if the herbal extract can truly combat cognitive decline. The findings, published in the Cochrane Database of Systematic Reviews, suggest that while the supplement is widely marketed for memory enhancement, its benefits are strictly limited to specific clinical diagnoses.

Disparity in Outcomes for Dementia versus Mild Impairment

The most significant finding of the review is the sharp divide in effectiveness between different stages of cognitive decline. For individuals already diagnosed with dementia, Ginkgo biloba may offer modest improvements in cognitive function and the ability to perform daily activities over a six-month period. However, for those experiencing "subjective" memory complaints or diagnosed with Mild Cognitive Impairment (MCI), the supplement appears to make little to no difference. This distinction is vital for consumers who often turn to herbal remedies at the first sign of age-related forgetfulness.

Methodological Challenges in International Clinical Trials

The research team faced significant hurdles in synthesizing data, as more than half of the identified studies were published in Chinese and many varied in their rigorousness. Lead author L. Susan Wieland, PhD, noted that while the dementia-related findings are statistically visible, confidence in these results remains low due to methodological limitations in the underlying trials. This inconsistency highlights a broader issue in integrative medicine, where the lack of standardized testing makes it difficult to definitively prove the efficacy of common over-the-counter supplements.